# Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation

Study · id `cardio:ct-nct02869022` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02869022](<https://clinicaltrials.gov/study/NCT02869022>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02869022

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT02869022. Randomized; single masking; primary purpose treatment. Start 2016-07 (actual); primary completion 2019-09-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT02869022, source copy `cardio:ctgov-nct02869022-2020-01-18`, retrieved 2026-10-26)
- Started: 2016-07 (actual) (ClinicalTrials.gov record NCT02869022, source copy `cardio:ctgov-nct02869022-2020-01-18`, retrieved 2026-10-26)
- Primary completion: 2019-09-02 (actual) (ClinicalTrials.gov record NCT02869022, source copy `cardio:ctgov-nct02869022-2020-01-18`, retrieved 2026-10-26)
- Completion: 2019-09-02 (actual) (ClinicalTrials.gov record NCT02869022, source copy `cardio:ctgov-nct02869022-2020-01-18`, retrieved 2026-10-26)
- Countries: Austria; Germany (ClinicalTrials.gov record NCT02869022, source copy `cardio:ctgov-nct02869022-2020-01-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02869022-2020-01-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation
- Condition: Heart Failure
- Intervention (Drug): Custodiol-N
- Intervention (Drug): Custodiol
- Intervention (Procedure): organ perfusion for heart transplantation
- Lead sponsor: Dr. F. Köhler Chemie GmbH
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Dr. F. Köhler Chemie GmbH (`cardio:org-dr-f-kohler-chemie-gmbh`)

## Provenance

Content hash: 37916ce95b3bf5700704b5f57384daa5270202c2c3da6599a0bf3b71e09bfccc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
